Literature DB >> 12956400

Association between coronary endothelial dysfunction and local inflammation of atherosclerotic coronary arteries.

Taku Matsubara1, Takaharu Ishibashi, Tomoyuki Hori, Kazuyuki Ozaki, Tohru Mezaki, Keiichi Tsuchida, Akimitsu Nasuno, Kaname Kubota, Takayuki Tanaka, Takashi Miida, Yoshifusa Aizawa, Matomo Nishio.   

Abstract

We have examined a possibility whether or not severity and extent of coronary atherosclerosis may associate with degree of local inflammation in relation to endothelial dysfunction as is indicated by reduced NO formation. Blood samples were obtained from aortic root (Ao) and coronary sinus (CS) of 39 patients who underwent coronary angiography. Plasma NOx levels (nitrite + nitrate, stable NO end-products) were evaluated by HPLC-Griess system, and markers of inflammation, C-reactive protein (CRP) and serum amyloid A protein (SAA), were measured by Latex Turbidimetric Immunoassay. To evaluate the changes of these substances through coronary circulation, the percentage changes of respective markers [(CS - Ao) x 100/Ao] were calculated. The extent and severity of atherosclerosis of left coronary arteries were evaluated with Gensini Score (GS). The GS correlated with the percentage changes of NOx (r = -0.35, p < 0.05) and that of SAA (r = 0.43, p < 0.05) across coronary circulation, but not with changes in CRP. Moreover, the percentage changes of NOx correlated with that of SAA (r = -0.36, p < 0.05). These results indicated that severity and extent of coronary atherosclerosis related to degree of local inflammation which has a possible association with coronary endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956400

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Role of novel markers of inflammation in patients with stable coronary heart disease.

Authors:  A Hoffmeister; D Rothenbacher; U Bäzner; M Fröhlich; H Brenner; V Hombach; W Koenig
Journal:  Am J Cardiol       Date:  2001-02-01       Impact factor: 2.778

2.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

3.  Nitric oxide activity in the atherosclerotic human coronary circulation.

Authors:  A A Quyyumi; N Dakak; D Mulcahy; N P Andrews; S Husain; J A Panza; R O Cannon
Journal:  J Am Coll Cardiol       Date:  1997-02       Impact factor: 24.094

4.  Generation of C-reactive protein and complement components in atherosclerotic plaques.

Authors:  K Yasojima; C Schwab; E G McGeer; P L McGeer
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

5.  Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits.

Authors:  T Esaki; T Hayashi; E Muto; K Yamada; M Kuzuya; A Iguchi
Journal:  Atherosclerosis       Date:  1997-01-03       Impact factor: 5.162

6.  Role of serum amyloid A during metabolism of acute-phase HDL by macrophages.

Authors:  A Artl; G Marsche; S Lestavel; W Sattler; E Malle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

7.  Negative NO3- difference in human coronary circulation with severe atherosclerotic stenosis.

Authors:  T Ishibashi; T Matsubara; T Ida; T Hori; M Yamazoe; Y Aizawa; J Yoshida; M Nishio
Journal:  Life Sci       Date:  2000       Impact factor: 5.037

8.  Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability.

Authors:  L M Biasucci; G Liuzzo; R L Grillo; G Caligiuri; A G Rebuzzi; A Buffon; F Summaria; F Ginnetti; G Fadda; A Maseri
Journal:  Circulation       Date:  1999-02-23       Impact factor: 29.690

9.  Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function.

Authors:  R L Meek; S Urieli-Shoval; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

10.  C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries.

Authors:  J Torzewski; M Torzewski; D E Bowyer; M Fröhlich; W Koenig; J Waltenberger; C Fitzsimmons; V Hombach
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-09       Impact factor: 8.311

View more
  5 in total

1.  Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women.

Authors:  Megha Prasad; Eric L Matteson; Joerg Herrmann; Rajiv Gulati; Charanjit S Rihal; Lilach O Lerman; Amir Lerman
Journal:  Hypertension       Date:  2016-12-19       Impact factor: 10.190

2.  Inflammation markers in patients with coronary artery disease--comparison of intracoronary and systemic levels.

Authors:  Simona Kirbis; Urska D Breskvar; Miso Sabovic; Igor Zupan; Andreja Sinkovic
Journal:  Wien Klin Wochenschr       Date:  2010-05       Impact factor: 1.704

3.  Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized Trial.

Authors:  Binita Shah; Michael Pillinger; Hua Zhong; Bruce Cronstein; Yuhe Xia; Jeffrey D Lorin; Nathaniel R Smilowitz; Frederick Feit; Nicole Ratnapala; Norma M Keller; Stuart D Katz
Journal:  Circ Cardiovasc Interv       Date:  2020-04-16       Impact factor: 6.546

4.  Acute phase proteins activation in subjects with coronary atherosclerosis and micro-vessel coronary circulation impairment.

Authors:  Natale Daniele Brunetti; Roberto Padalino; Luisa De Gennaro; Andrea Cuculo; Luigi Ziccardi; Pier Luigi Pellegrino; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2008-08-09       Impact factor: 2.300

5.  Low-grade systemic inflammation profile, unrelated to homocysteinemia, in obese children.

Authors:  Emanuel V Economou; Ariadne V Malamitsi-Puchner; Christos P Pitsavos; Evangelia E Kouskouni; Ioanna Magaziotou-Elefsinioti; George Creatsas
Journal:  Mediators Inflamm       Date:  2005-12-14       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.